PANAX DIARREX 200MG/5ML ORAL 120ML SUSP

INDICATIONS INFECTIOUS DIARRHEA IN CHILDREN AND ADULTS CHRONIC COLITIS ENTEROCOLITIS AS AN ADJUNCTIVE TREATMENT IN COMBINED THERAPY OF INTESTINAL DYSBIOSIS. CONTRAINDICATION HYPERSENSITIVITY TO 5-NITROFURANE DERIVATIVES AND/OR OTHER COMPONENTS OF THE DRUG. DOSAGE AND ADMINISTRATION NIFUROXAZIDE SHOULD BE TAKEN ORALLY WITH OR WITHOUT MEALS. ADULTS AND CHILDREN OVER 6 YEARS OF AGE - 1 TABLET 4 TIMES DAILY (A DAILY DOSE - 800 MG). THE TREATMENT COURSE IS 5 - 7 DAYS. SIDE EFFECTS NIFUROXAZIDE IS WELL TOLERATED; HOWEVER THE FOLLOWING EFFECTS MAY BE OCCASIONALLY OBSERVED: GASTROINTESTINAL DISORDERS: SHORT-TERM ABDOMINAL PAIN NAUSEA AGGRAVATION OF DIARRHEA. HYPERSENSITIVITY REACTIONS (REQUIRE DISCONTINUATION OF THE DRUG): RESPIRATORY DISORDERS: ASTHMA; SKIN DISORDERS: RASH PRURITUS.